Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Prizes
Spin-Offs
Media
Activities
Datasets
Search by expertise, name or affiliation
Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis
the German IBD Study Group
Clinic of Internal Medicine I
Clinic of Psychiatry and Psychotherapy
Asklepios Klinik St. Georg
Friedrich Schiller University Jena
University of Kiel
Martin Luther University
Universitätsklinikum Carl Gustav Carus
Waldfriede Hospital
65
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Pouchitis
100%
Side Effect
33%
Disease Activity
33%
Antibiotic Therapy
33%
Inflammatory Bowel Disease
16%
Ileo-Anal Pouch
16%
Opiate
16%
Loperamide
16%
Pharmacology, Toxicology and Pharmaceutical Science
Ileitis
100%
Disease Activity
33%
Side Effect
33%
Inflammatory Bowel Disease
16%
Loperamide
16%
Tincture
16%
Opiate
16%